Systematic Review of Antidepressants in the Treatment of Chronic Low Back Pain

Spine

Volumn 28, Issue 22, 2003, Pages 2540-2545

  Staiger, Thomas O ^a,b   Gaster, Barak ^a   Sullivan, Mark D ^a   Deyo, Richard A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE   (United States)

Author keywords

Antidepressive agents; Chronic pain; Low back pain

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; IMIPRAMINE; MAPROTILINE; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALGESIA; ANALGESIC ACTIVITY; CHRONIC PAIN; CLINICAL TRIAL; COCHRANE LIBRARY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HUMAN; LOW BACK PAIN; MEDLINE; METHODOLOGY; NORADRENALIN UPTAKE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCINFO; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REVIEW; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; TREMOR; URINARY DYSFUNCTION; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; HUMANS; LOW BACK PAIN; RANDOMIZED CONTROLLED TRIALS;

EID: 0344064091     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.BRS.0000092372.73527.BA     Document Type: Review

References (47)

1. Cypress BK. Characteristics of physician visits for back symptoms: A national perspective. Am J Public Health 1983;73(4):389-395.
2. Andersson GBJ. The epidemiology of spinal disorders. In: Frymoyer JW, ed. The adult spine: principles and practice. New York: Raven Press; 1991:107-146.
3. Loeser JD, Volinn E. Epidemiology of low back pain. Neurosurg Clin North Am 1991;2:713-718.
4. Von Korff M, Saunders K. The course of back pain in primary care. Spine 1996;21:2833-2837.
5. Cassidy JD, Carroll LJ, Cote P. The Cassidy Saskatchewan health and back pain survey. Spine 1998;23:1860-1866.
6. Elliot AM, Smith BH, Penny KI, et al. The epidemiology of chronic pain in the community. Lancet 1999;354:1248-1252.
7. van Tulder MW, Koes BW, Bouter LM. Conservative treatment of acute and chronic nonspecific low back pain. Spine 1997;22:2128-2156.
8. Sindrup SH, Jensen TS. Efficacy of pharmacologic treatments of neuropathic pain. Pain 1999;83(3):389-400.
9. O'Malley PG, Balden E, Tomkins G, et al. Treatment of fibromyalgia with antidepressants. JGIM 2000;15:659-666.
10. O'Malley PG, Jackson JL, Tompkins GE, et al. Efficacy of antidepressants for physical symptoms. J Fam Pract 1999;48:980-990.
11. Ramadan NM, Schultz LL, Gilkey SJ. Migraine prophylactic drugs. Cephalgia. 1997;17:73-80.
12. Jung AC, Staiger T, Sullivan M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J Gen Int Med 1997;12:384-389.
13. McQuay HJ, Tramer M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-227.
14. Broadhead WE, Larxon DB, Yarnall KS, et al. Tricyclic antidepressant prescribing for nonpsychiatric disorders. J Fam Pract 1991;33:24-32.
15. Di Iorio D, Henley E, Doughty A. A survey of primary care physician practice patterns and adherence to acute low back pain problem guidelines. Arch Fam Med 2000;9:1015-1021.
16. Linton SJ. A review of psychological risk factors in back and neck pain. Spine 2000;25:1148-1156.
17. Turner JA, Denny MC. Do antidepressant agents relieve chronic low back pain? J Fam Pract 1993;37:545-553.
18. Salerno SM, Browning R, Jackson JL. The effect of antidepressant treatment on chronic back pain. Arch Intern Med 2002;162:19-24.
19. Ward N, Bokan JA, Phillips M, et al. Antidepressants in concomitant chronic back pain and depression. J Clin Pscyh 1984;45:54-57.
20. Ward NG. Tricyclic antidepressants for chronic low-back pain. Spine 1986; 11:661-665.
21. van Tulder MW, Assendelft WJ, Koes BW, Bet al. Method guidelines for systematic reviews in the cochrane collaboration back review group for spinal disorders. Spine 1997;22:2323-2330.
22. Rush J, Golden WE, Hall GW, et al. Depression in primary care, volume 2. Treatment of major depression. Rockville, MD. US Dept. of Health and Human Services, Agency for Health Care Policy and Research. AHCPR Pub. No. 93-0551, April 1993.
23. nd ed. Hillsdale, NJ: Lawrence Erlbaum Assoc; 1988.
24. Alcoff J, Jones E, Rust P, et al. Controlled trial of imipramine for chronic low back pain. J Fam Pract 1982;14:841-846.
25. Atkinson JH, Slater MA, Wahlgren DR, et al. Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain 1999; 83:137-145.
26. Atkinson JH, Slater MA, Williams RA, et al. A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain 1998;76: 287-296.
27. Davidson JR, France RD. Bupropion in chronic low back pain. J Clin Psych 1994;55:362.
28. Desproges-Gotteron R, Abramom JY, Borderie J, et al. [Current therapeutic possibilities in lumbago of neurotic origin.] Rhumatologie 1970;22:223-226.
29. Dickens C, Jayson M, Sutton C, et al. The relationship between pain and depression in a trail using paroxetine in suffers of chronic low back pain. Psychosomatics 2000;41:490-499.
30. Fouquet B, Goupille P, Jeannou J, et al. Influence of psychological factors on the response to clomipramine in hospitalized chronic low back pain patients. Rev Rhum Engl Ed 1997;64):804-808.
31. Gardela G. [Value of adjuvant treatment with imipramine for lumbosacral pain syndrome.] Pol Tyg Lek 1991;46:544-546.
32. Goodkin K, Gullion DM, Agras WS. A randomized, double-blind, placebo-controlled trial of trazodone hydrochloride in chronic low back pain syndrome. J Clin Psychopharmacol 1990;10:269-278.
33. Hameroff SR, Cork RC, Scherer K, et al. Doxepin effects on chronic pain, depression, and plasma opioids. J Clin Psychiatry 1982;43:22-26.
34. Hameroff SR, Weiss J, Lerman JC, et al. Doxepin's effects on chronic pain and depression. J Clin Psychiatry 1984;45:47-52.
35. Jenkins DG, Ebbutt AF, Evans CD. Tofranil in the treatment of low back pain. J Int Med Res 1976;4(S2):28-40.
36. Kocher R. [The treatment of chronic low back pain with psychotropic drugs.] MMW Munch Med Wochenschr. 1977;119:1241-1244.
37. Loldrup D, Langemark M, Jansen HJ, et al. Clomipramine and mianserine in chronic idiopathic pain syndrome. Psychopharmacol 1999;99:1-7.
38. Pheasant H, Bursk A, Goldfarb J, et al. Amitriptyline and chronic low back pain. Spine 1983;8(5):552-557.
39. Screiber S, Vinokur S, Shavelzon V, et al. A randomized trial of fluoxetine versus amitriptyline in musculo-skeletal pain. Isr J Psychiartry Relat Sci 2001;38:88-94.
40. Songer DA, Schulte H. Venlafaxine for the treatment of chronic pain. Am J Psych 1996;153:737.
41. Stein D, Peri T, Edelstein E, et al. The efficacy of amitriptyline and acetaminophen in the management of acute low back pain. Psychosomatics 1996;37: 63-70.
42. Storch H, Steck P. [Concommitant thymoleptic therapy in the frame of a controlled study with maprotiline (Ludiotnil) in the treatment of backache.] Nervenarzt 1982;53:445-450.
43. Treves R, Montaine de la Roque P, Bumond JJ, et al. [Prospective study of the analgesic action of clomipramine versus placebo in refractory lumbosciatica.] Rev Rhum Mal Osteoartic 1991;58:549-552.
44. Onghena P, Houdenhove BV. Antidepressant-induced analgesia in chronic non-malignant pain. Pain 1992;49:205-219.
45. Max, MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37:589-596.
46. Williams JW, Mulrow CD, Chiquette E, et al. A systematic review of newer pharmacotherapies for depression in adults. Ann Intern Med 2000;132:743-758.
47. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990;263:1385-1389.